---
layout: default
---

# Configurations

| UniProt Accession Number   | Reagent Type     | Target Name / Protein Biomarker   | Target Species   | Host Organism   | Isotype   | Clonality   | Vendor    |   Catalog Number | Conjugate    | RRID       | Availability   | Method        | Tissue Preservation               | Target Tissue   | Tissue State   | Detergent         | Antigen Retrieval Conditions   | Dye Inactivation Conditions   | Recommend   | Agree               | Disagree   | Contributor         | Notes       |
|:---------------------------|:-----------------|:----------------------------------|:-----------------|:----------------|:----------|:------------|:----------|-----------------:|:-------------|:-----------|:---------------|:--------------|:----------------------------------|:----------------|:---------------|:------------------|:-------------------------------|:------------------------------|:------------|:--------------------|:-----------|:--------------------|:------------|
| P16070                     | Primary Antibody | CD44                              | Human            | Rat             | IgG2b     | IM7         | BioLegend |           103074 | Spark YG 570 | AB_2892265 | Stock          | IBEX2D Manual | 1:4 Cytofix/Cytoperm Fixed Frozen | Thymus          | NA             | 0.3% Triton-X-100 | NA                             | NA                            | Yes         | [0000-0003-4379-8967](https://orcid.org/0000-0003-4379-8967) | NA         | [0000-0003-4379-8967](https://orcid.org/0000-0003-4379-8967) | [1](#notes) |

# Publications



# Additional Notes

<a name="notes"></a>
1. Clone IM7 labels various cell types and cell states in diverse mouse and human tissues. Several conjugates are suitable for Multiplexed 2D Imaging and IBEX imaging. Antibody yields a great signal; however, the Spark YG570 conjugate does not dye inactivate within 15 minutes of 1 mg/ml LiBH4 treatment. Additional dye inactivation conditions need to be tested. This antibody could be placed in the last cycle or used as a fiducial.
